XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income taxes (Details) - Schedule of Significant Components of the Company’s Deferred Tax Assets and Liabilities - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Schedule of Significant Components of the Company’s Deferred Tax Assets and Liabilities [Abstract]    
Net operating loss carryforwards $ 10,860 $ 8,742
Capitalized research and development expense 3,058 1,933
Stock-based compensation expense 2,818 2,587
Research and development tax credits 2,568 1,658
Property and equipment 193 105
Total deferred tax assets 19,497 15,025
Section 179 assets (239) (111)
Reserves, accruals and other (49) (92)
Total deferred tax liabilities (288) (203)
Less: valuation allowance (19,209) (14,822)
Deferred tax assets, net